@article{JTD19862,
author = {Jacopo Fumagalli and Lorenzo Berra},
title = {What does the Acute Respiratory Distress Syndrome trial (ART) teach us?—it is time for precision medicine and precision trials in critical care!},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Acute respiratory distress syndrome (ARDS) affects a remarkable proportion of patients admitted to the intensive care unit (ICU) and according to a recent international survey, mortality attributable to ARDS remains high (≈40%) (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/19862}
}